Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-29

FDA Approved: ADRENALIN — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for ADRENALIN (epinephrine) filed by Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADRENALIN (Epinephrine)

Snippet

SUPPL AP for ADRENALIN (EPINEPHRINE)